B, N.H. et al. 2021. The Thromboembolism and Bleeding Event in Patients Receiving Warfarin, Dabigatran, or Rivaroxaban in Nonvalvular Atrial Fibrillation. PHARMACY: Jurnal Farmasi Indonesia (Pharmaceutical Journal of Indonesia). 18, 2 (Dec. 2021), 453–459. DOI:https://doi.org/10.30595/pharmacy.v18i2.13315.